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Many  countries  and  communities  are  dealing  with  groups  and  growing  numbers  of individuals  who  are
delaying  or  refusing  recommended  vaccinations  for themselves  or their  children.  This  has  created  a  need
for immunization  programs  to  ﬁnd  approaches  and  strategies  to address  vaccine  hesitancy.  An  impor-
tant  source  of useful  approaches  and  strategies  is  found  in  the frameworks,  practices,  and  principles
used  by  commercial  and  social  marketers,  many  of which  have  been  used  by  immunization  programs.
This  review  examines  how  social  and commercial  marketing  principles  and practices  can  be used  to  help
address  vaccine  hesitancy.  It provides  an  introduction  to  key  marketing  and  social  marketing  concepts,
identiﬁes  some  of the  major  challenges  to  applying  commercial  and  social  marketing  approaches  to
immunization  programs,  illustrates  how  immunization  advocates  and  programs  can  use  marketing  and
social marketing  approaches  to address  vaccine  hesitancy,  and  identiﬁes  some  of  the  lessons  that  com-
mercial  and  non-immunization  sectors  have  learned  that  may  have  relevance  for  immunization.  While
the use of  commercial  and  social  marketing  practices  and  principles  does  not  guarantee  success,  the  evi-
dence,  lessons  learned,  and  applications  to date  indicate  that  they  have  considerable  value in fostering
vaccine  acceptance.
©  2015  Published  by  Elsevier  Ltd.  This  is an open  access  article  under  the  CC  BY  license  (http://. Introduction
Many countries and communities are dealing with groups
nd/or growing numbers of individuals who are delaying or refus-
ng available recommended vaccinations for themselves and/or
heir children [1–3]. Recognizing that the factors underlying these
ecisions are varied and that no single intervention strategy can
olve the problem [1–5], the SAGE Working Group on Vaccine
esitancy (WG) placed emphasis in their recommendations on
dentifying and evaluating approaches that are designed to better
 Some of the authors are World Health Organization staff members. The opinions
xpressed in this article are those of the authors and do not necessarily represent
he decisions, ofﬁcial policy or opinions of the World Health Organization.
∗ Corresponding author.
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ttp://dx.doi.org/10.1016/j.vaccine.2015.04.039
264-410X/© 2015 Published by Elsevier Ltd. This is an open access article under the CC creativecommons.org/licenses/by/3.0/).
understand and to decrease vaccine hesitancy [6]. Among the
strategies assessed by the working group was  the Tailoring Immu-
nization Programs (TIP) initiative developed by the WHO  Regional
Ofﬁce for Europe, which is based upon social marketing princi-
ples and behavioral insight methodology [7,8], along with insights
gained from discussions with commercial marketing and social
marketing experts involved in health and non-health related appli-
cations that might be applicable to vaccine hesitancy [6]. The
potential value of social marketing has also been recognized by
immunization programs and advocates [8–11] including possible
application to vaccine hesitancy [12–14].
This review builds on the WG’s interest in commercial and social
marketing principles and practices to help address vaccine hesi-
tancy, providing an introduction to social marketing and overviews
of: (1) challenges to the marketing and social marketing approach
when applied to immunization programs, (2) how immunization
advocates and programs have used marketing or social market-
ing approaches or core elements of it to address hesitancy, and (3)
lessons from commercial and non-immunization sectors that may
BY license (http://creativecommons.org/licenses/by/3.0/).
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ave relevance for immunization. It also reafﬁrms the value of, and
he need for, evaluating efforts that use such practices and princi-
les, both to build the evidence base and to assess their impact, if
ny, on vaccine hesitancy or acceptance.
. Introduction to marketing and social marketing
As deﬁned by the American Marketing Association, “market-
ng” is the activity, set of institutions, and processes for creating,
ommunicating, delivering, and exchanging offerings that have
alue for customers, clients, partners, and society at large [15].
arketing is based on the notion that products and services are
ost likely to be successful – i.e. purchased or taken up – if they
re focused on identifying, addressing and satisfying the needs of
urrent and potential customers [16]. Individuals’ purchasing or
uying behaviors are seen as “exchanges of value” that beneﬁt
oth the buyer and the seller, with a marketer’s branded prod-
ct or service being perceived by the customer as the one that
est meets their needs. Social marketing represents the extension
f this thinking to the “selling” of ideas, attitudes and behaviors,
sually ones characterized as “pro-social” or focused on improving
he health and well-being of both the targeted individuals and the
roader community or society (e.g. preventing or reducing tobacco
se, promoting physical activity, and sharing nutrition recommen-
ations) [17–20]. Thus, while the outcomes of interest differ – with
ommercial marketers focused on persuading consumers to value
nd purchase branded products or services, and social marketers
ocused on encouraging individuals to value and adopt advocated
deas and recommended actions – in the end, both are intended to
nform and inﬂuence a decision that affects a behavior. Thus, there
s much commonality in the approaches, practices, and principles
uiding the application.
Social marketing takes commercial marketing principles and
pplies them to inﬂuence target audience behaviors that will ben-
ﬁt the individual and society, i.e. its primary goal is public good.
ocial marketing thus provides a potentially helpful lens when
xamining immunization program issues such as hesitancy. As the
G and others have noted [1–5,21], dealing with vaccine hesitancy
ithin a country or subgroup requires developing an understand-
ng of the magnitude and setting of hesitancy, developing and
alidating metrics that allow monitoring trends over time, a diag-
osis of the root cause or causes, tailored evidence-based strategies
o address the causes, and evaluation of the effects and impact
f the interventions. Social marketing provides a framework for
oing this as it focuses on creating, communicating, delivering, and
xchanging offerings that have a positive value for the segmented,
argeted audiences and partners within the constraints of available
esources [12,18–20].
. The four “P’s”: product, price, place and promotion
At the heart of marketing and social marketing are the four
P’s” – Product, Price, Place and Promotion [16–18]. These are the
our major categories used to create, communicate, and deliver
alue to target populations, with each category containing ele-
ents that can be changed or varied in order to make an offering,
ervice, idea, recommendation, or the adoption of a behavior more
ttractive and appealing. The “Product” includes the actual features
r characteristics of the offering, the beneﬁts derived or received
rom using the offering or performing the advocated behavior, and
ow the offering relates to the end user’s interests and needs.
he “Price” encompasses the costs associated with the offering
r behavior, including money, time, physical and psychological
e.g. cognitive processing expended) efforts, while “Place” encom-
asses access, accessibility, distribution and convenience. Price and3 (2015) 4204–4211 4205
place considerations often place a priority on creating or fostering
easy, convenient access to marketed products, services, or things
that enable adoption of recommended behaviors. The fourth “P”
– “Promotion” comprises the persuasive communication factors
used to highlight product features/beneﬁts, its price or costs, and
where/how to obtain the offering. The promotion category includes
the creative strategy, the media and message delivery channels,
the messengers or spokespersons, and the messages to be used
[9,13,18].
In social marketing, the product is often the behavior that is
being advocated, while the price can include the investment in
time and/or effort to make a decision that results in the desired
behavior, the social value of following the perceived community
consensus (or, conversely, the social costs of not complying with
a perceived norm), as well as the provision of monetary subsi-
dies to foster adoption of the advocated behavior [12,17,18]. Two
additional “P’s” – “Partnerships” and the “Participation” of key stake-
holders – are also frequently used to help accomplish public health
goals, including through the establishment of social norms and via
policy-maker engagement [19].
In both marketing and social marketing, the 4 “P’s” are combined
into a “marketing mix” or a comprehensive strategy that utilizes all
the major categories in an effort to inform a decision that affects vol-
untary behavior or behavior change (i.e. neither is about coercion
or enforcement) [20]. The marketing mix  and speciﬁc efforts are
also usually grounded in: (1) a situation analysis that provides an
assessment of the context in which the campaign or intervention is
to be launched; (2) research that helps identify different population
groups or segments, including the cognitive and behavioral deter-
minants of action or inaction associated with each; (3) engagement
of stakeholders and partner organizations, such as those involved
in delivering or providing the service; and (4) promotional strate-
gies and messages based on insights gained from audience research,
feedback or engagement [12,17–20,23].
4. Overview of application of social marketing to address
immunization and vaccine-hesitancy
Social marketing introduces the ﬁeld of immunization to brand
positioning and prompts programs to think about the value of
immunization in a different way; what is the ‘brand’ and how
is it perceived? What are the immunization program product’s
attributes and beneﬁts as seen through the eyes of the individ-
uals for whom vaccination is recommended or of the parents for
whose children vaccination is recommended? Immunization pro-
gram planners need to consider how to best promote vaccine and
vaccination beneﬁts from the perspective and needs of the hesi-
tant caregivers, individuals, and communities, rather than from the
program planner perspective.
Social marketing also introduces tactical segmentation of the
population going beyond mere background characteristics, by
drawing on consumer market research and analysis to consider
demographic and psychographic characteristics, population mem-
bers’ subjective experiences with immunization, their intention to
perform the advocated behavior, their medical histories, cultures
and environments. These help form a more complete picture of the
population that goes well beyond traditional healthcare proﬁling
and characterization. Social marketing also involves the determina-
tion/identiﬁcation of the key inﬂuencers, gate keepers, and agents
of change within the population as information provision alone
does not determine behavior – it also matters who  is providing
vaccination-related information and how it is provided. Social mar-
keting therefore, seeks/encourages an enhanced understanding of
how different subgroups in the targeted population are likely to
be persuaded given that hesitancy varies and is not uniform across
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he population, and the factors inﬂuencing hesitation are not the
ame across the subgroups [21,22]. Some subgroups may  be more
ifﬁcult to address or persuade [8,14] and therefore knowing how
ubgroups differ from each other is essential. Context timing and
accine also matter. Applying social marketing to immunization
akes a very clear distinction between hesitancy toward new vac-
ine introduction and hesitancy regarding older vaccines such as
he measles–mumps–rubella (MMR)  vaccine.
Social marketing not only helps immunization programs
dentify and understand the physical, social, and economic envi-
onmental factors that play a major role in determining vaccine
cceptance; it also calls attention to the need to examine
mmunization convenience [7,8,18]. Social marketing encourages
onsideration of alternative methods and outlets to reach their tar-
et populations, according to their proﬁles. Marketers focus much
f their attention on how their products are delivered and whether
he delivery channels and places where the product is offered meet
he needs of the population in question. Social marketers consider
ot only the problematic barriers that prevent the desired behav-
or but also the positive behaviors and their determinants that need
o be encouraged and promoted to support the desired behavior
19,22]. This is particularly important in addressing vaccine hesi-
ancy where the majority of the people or parents in the population
re already performing the desired behavior, i.e. accepting vac-
ines according to the schedule. For those who are not performing
he desired behavior, the key questions are: “Are there approaches
hat can move or ‘nudge’ them toward vaccine acceptance?” [23]
s the “selling” of long-term or short-term beneﬁts the most ben-
ﬁcial? Would it be more effective to emphasize the immediate
eneﬁts of being vaccinated, such as feeling safe and being a good
arent, rather than on the longer-term beneﬁt of not contracting
he disease? What factors can help the hesitant join the acceptance
roup?
Thus social marketing applied to immunization has a focus on
nd-user outcomes, i.e. public and individual good, and is end-user
riven [19,24]. It presents systematic ways and tools to engage
ommunities and facilitates empowerment and ownership through
ts belief in community solution efﬁcacy, where the answer usually
xists within the community and the social marketer merely facili-
ates the process so that the community draws its own  conclusions
nd thus ‘owns’ the outcome.
. Lessons learned
What is known about the marketing and communication prac-
ices championed in other public health applications (e.g. tobacco
nitiation and cessation, physical activity, alcohol prevention) [24]
nd by commercial and non-proﬁt enterprises, along with social
arketing principles, that could be applied to immunization [21]?
n fact, as a number of published guidance documents and stud-
es illustrate, many immunization programs and providers have
sed marketing and social marketing frameworks and elements to
romote vaccinations and adherence to recommended vaccination
chedules. These include as noted above the WHO  Regional Ofﬁce
or Europe’s Guide to Tailoring Immunization Programs (TIP) (2013);
HO’s HPV Vaccine Communication: Special Considerations for a
nique Vaccine (2013); The Health Communication Capacity Collab-
rative’s The P Process: Five Steps to Strategic Communication (2013);
nd the U.S. Centers for Disease Control and Prevention’s CD Cyn-
rgy Social Marketing (http://www.orau.gov/cdcynergy/soc2web/
efault.htm). Typically, in these efforts, the speciﬁc vaccines, the
ecommended immunization schedule, or the act of getting vac-
inated are characterized as the “Product”; the ﬁnancial costs, the
onvenience and ease of access to the vaccine or immunization ser-
ices and perceptions of safety and efﬁcacy and value to individuals3 (2015) 4204–4211
and the community are in the “Price” category; where the vac-
cine is obtained or administered (e.g. doctors’ ofﬁces, clinics, retail
outlets) in the “Place”; and messages, communication materials
(e.g. posters, brochures, websites, public service advertisements),
news media outreach and stories, spokespersons, and interpersonal
communication (e.g. provider–parent communication) fall in the
“Promotion” category [12,25].
6. Challenges in application of marketing and social
marketing to immunization
In considering social marketing uses and commercial sector
practices that may  have value for addressing vaccine hesitancy, it
is important to recognize that public health efforts related to vac-
cination often face challenges different from those faced by other
marketers and programs. These challenges can make it difﬁcult,
or in some cases, not possible, for immunization programs and
other health efforts to apply strategies or tactics found in the com-
mercial sector. In discussions with marketing experts, for instance,
the Working Group on Vaccine Hesitancy [6] noted that these
challenges included: (a) the ﬁnancial and resource costs that large-
scale (e.g. national) marketing campaigns often require or need; (b)
achieving the very high adoption or compliance rates that immu-
nization programs need to achieve for there to be a population
beneﬁt (i.e. a high proportion of people have to accept vaccina-
tion for herd immunity to be attained); (c) using the social media
approach in areas where not everyone has access; (d) the inﬂuence
of health-care workers on vaccination decision making is large; (e)
the beneﬁt from vaccines lies in the prevention of a bad event that
may or may  not actually occur as opposed to a good event happen-
ing (i.e. it provides a less tangible or appreciated outcome); and (f)
narrowing the social marketing approach to the 4Ps may  restrict
vision and limit opportunities as ignorance of contextual factors
may  totally undermine the best planning [4,7,8].
In addition, because public health vaccination programs are
about health rather than proﬁt, there are ethical issues such as
beneﬁcence and justice that need to be considered. Further, while
commercial sector ﬁrms face competition from other product or
service offerings, vaccination programs struggle with anti-vaccine
movements, political groups that oppose or ban vaccination, and
social/cultural norms within certain communities. If lack of trust
underlies vaccine hesitancy, the source or issue may  or may  not be
vaccine-related – often, distrust in vaccines may  reﬂect or emanate
from a broader distrust of health providers, the health system or
the government and/or politics [22].
7. Field examples of immunization-related use of
marketing and social marketing
Marketing and social marketing frameworks and principles have
been used or incorporated into efforts designed to foster vaccina-
tion acceptance. A good example is the “Immunize Australia” public
health social marketing campaign undertaken in 1997 by the Aus-
tralian government [9]. The effort was in response to a 1995 survey
that found only 33 percent of Australian children up to 6 years of
age were fully immunized according to the schedule being recom-
mended at the time. A number of initiatives were implemented,
including a social marketing strategy that involved formative (com-
munication) research with parents; using the research to identify
different parent groups or segments (i.e. as the basis for a segmen-
tation strategy); grounding the communication strategy in both
the research and a theoretical framework (in this case, the Health
Belief Model); and including activities directed at immunization
service providers to increase and reinforce their knowledge levels
and support for immunization [9].
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While there are many factors that can result in low vac-
ination coverage rates, the formative communication research
ndertaken as part of “Immunize Australia” found two major bar-
iers to full immunization, one practical and one medical. Each,
n turn, encompassed beliefs often associated with vaccine hesi-
ancy. On the practical side, many parents did not recognize the
mportance of the precise timing and number of vaccinations;
nd medical factors included a lack of belief in the seriousness
f some vaccine preventable diseases, a fear of side-effects that
s out of proportion to their actual occurrence, and postpon-
ng vaccinations if a child was ill because of the belief that the
accine would exacerbate the child’s illness and/or that the resul-
ant immune response would be suboptimal. The multifaceted
ocial marketing campaign included developing and distributing
n Australian Immunization Handbook to over 60,000 immuniza-
ion service providers, opening new communication channels to
eep providers updated, launching a community/parent education
ampaign that included television and magazine advertisements as
ell as posters in clinics, hospitals and doctors’ ofﬁces, and a series
f Immunization Awareness Days. In addition to the social market-
ng campaign, a National Centre for Immunization Research and
urveillance was established, school-entry immunization require-
ents were initiated, and efforts to improve vaccine service
elivery were undertaken [9]. The overall effort resulted in
ncreased awareness of the immunization schedule, greater recog-
ition of the importance of recommended vaccinations, and more
hildren being immunized as recommended (e.g. 91 percent by
une 2001) [9].
In the United States, outbreaks of vaccine preventable disease
mong unvaccinated children prompted Opel et al. [12] to advo-
ate the use of social marketing to foster timely immunization in
hildren from birth to age 24 months. They believed social mar-
eting would be helpful for two reasons: (1) a “one-size-ﬁts-all”
pproach to health promotion was unlikely to succeed given the
ften diverse or varied reasons for parent delay or refusal of recom-
ended vaccinations; and (2) social marketing approaches utilize
arketing principles and techniques to inﬂuence the voluntary
ehavior of target audiences. They also noted the value of applying
ocial marketing strategies such as segmenting the larger popu-
ation of all parents of children aged two years and younger, into
peciﬁc segments based on knowledge, attitudes, and behaviors
KABs) and then using communication research, social psychol-
gy and communication science to develop a marketing mix  that
an be implemented to achieve the desired behavior or behavior
hange. Opel et al. described how Washington state, which in 2008
anked 46th among U.S. states in immunization rates, used social
arketing principles to guide the development of a campaign that
argeted parents who were expecting or currently had a child up
o age 24 months and were hesitant toward immunizations. The
pplication of social marketing involved formative research with
arents in this group to identify barriers and facilitators of vaccina-
ion, communication materials and messages that addressed myths
r misunderstandings related to immunization recommendations,
nd engagement/inclusion of health-care providers to better focus
onversations with parents to address their speciﬁc questions and
oncerns. For example, whereas immunization communication
rameworks often suggest discussing vaccines in a participatory
nd open manner, a 2013 study by Opel et al. found that health-care
roviders who used directive and presumptive discussion styles
ere more effective in improving vaccine acceptance in hesitant
iddle to upper class parents/caregivers studied in Seattle, USA
26].
The Netherland’s joint DELTA Companion: Marketing Planning
ade Easy tool [27] provides another example of how social mar-
eting planning tools can be used to obtain high-grade audience
nsight and brand positioning to assist programs in creating a3 (2015) 4204–4211 4207
situation analysis that allows clear and concise marketing objec-
tives to be deﬁned.
Social marketing has also been used in speciﬁc contexts related
to vaccination acceptance and hesitancy: (1) to foster acceptance
of a newly recommended vaccine and (2) to foster acceptance of
a speciﬁc vaccination recommendation, as shown in the examples
below.
8. Vaccine speciﬁc social marketing examples
8.1. Human papilloma virus (HPV) vaccines
Human papilloma virus (HPV) vaccines were licensed and rec-
ommended in a number of countries beginning in the mid-2000s.
HPV vaccination recommendations in many countries were met
with concerns and hesitancy on the part of parents and in some
cases, health-care providers. One result was  application of social
marketing frameworks and principles as a way to address concerns
regarding the safety, efﬁcacy, and need for vaccination, and to over-
come hesitancy among both parents and healthcare providers. Two
helpful outcomes of these efforts were: (1) identifying determi-
nants of HPV vaccine acceptance; and (2) providing insights related
to messages and messaging. Lack of awareness of the vaccination
recommendation, lack of knowledge related to cervical cancer, and
perceptions regarding vaccine risks and efﬁcacy were common
facilitators of hesitancy or barriers to acceptance [11,25,28]. How
the messaging around the basis for and the value of the vaccination
was framed, positioned and communicated was often important
with respect to HPV because it could be associated with behavioral
risk factors (e.g. sexual transmission). Groups and people who were
opposed to HPV vaccination for a variety of reasons, often worked to
shift the focus of the discussion from cancer prevention to vaccine
safety, teen sexuality, and parents’ rights. Vaccine acceptance was
most likely to happen where cervical cancer prevention was  the
predominant and most accepted focus [28,29], including in African
countries [30].
Efforts to identify facilitators of the HPV vaccination have
also emphasized the importance of well-informed physicians and
health-care workers. Studies have not only documented the value
of and need for a strong provider recommendation in order to
overcome parent hesitancy [31,32], but also the consequences of
providers themselves being reluctant with respect to the vaccine.
McRee et al. [28], for instance, found that if health-care providers
perceived large numbers of parents to be hesitant about the HPV
vaccine, the providers were less inclined to recommend the HPV
vaccination. This happened either because they were reluctant to
embark on a conversation about sexual and reproductive health
with the parent of a young adolescent, or because they believed that
they would not be able to change the parents’ opinions for different
reasons, including because they lacked the interpersonal commu-
nication skills to do so. Thus, in line with marketing and social
marketing practices and principles, it is often the case that inter-
vention efforts (e.g. a social marketing campaign) need to include
providing those responsible for delivering a service (e.g. physicians
and nurses), with the communication resources and training that
they need to be able to foster acceptance in their target popula-
tion (e.g. guidance and materials for effective conversations with
hesitant parents).
8.2. Poliovirus vaccine; haemophilus inﬂuenzae type b vaccineThese principles have also been applied successfully in mid-
dle and low income countries by UNICEF and others for the
poliovirus vaccine. For example, the Global Polio Eradication Initia-
tive, in partnership with the Government of Pakistan, used social
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arketing principles to develop programs that speciﬁcally address
eeds and concerns of those living in the Federally Administered
ribal Areas where polio transmission has been persistent, includ-
ng the development of transit clinics to vaccinate those on the
ove [33]. Similarly, Hajjeh in 2011, in describing factors that
acilitated the introduction of Haemophilus inﬂuenzae type b (Hib)
accine as part of the Gavi Hib Initiative, noted that a number
f marketing and communication principles were associated with
igher and better acceptance [34]. These included communication
trategies that ensured decision-makers and other stakeholders
ad timely access to Hib disease information that was relevant and
nderstandable; extensive communication and advocacy efforts
hat increased health-care provider and public awareness about the
ublic health importance of Hib disease and Hib vaccine; extensive
ngagement with health-care providers to inform the development
f Hib messaging; and framing of the Hib vaccine as an important
ool for overall pneumonia prevention.
.3. Inﬂuenza vaccine
Marketing and social marketing practices and principles have
een used to address hesitancy and foster greater acceptance
f long recommended vaccines, particularly those with uptake
ates far below those that are needed and desired, such as with
he inﬂuenza vaccine. One of the most commonly used prac-
ices is qualitative research, including focus group discussions,
o learn more about the differences between those who decline
r hesitate when it comes to getting the inﬂuenza vaccination,
nd those individuals who routinely receive a seasonal inﬂuenza
accination. Bhat-Schelbert et al., for example, conducted focus
roups with parents, teenagers, pediatric health-care staff, and
mmunization and marketing experts, to identify potential bar-
iers, facilitators, and strategies for child inﬂuenza vaccination
35]. They found that concerns about vaccine adverse events,
kepticism about vaccine effectiveness, and lack of trust in
hose recommending the inﬂuenza vaccination, fostered hesitancy,
articularly among parents. Conversely, parents who had their chil-
ren vaccinated were motivated by a desire to prevent inﬂuenza,
ncluding the transmission to others. With respect to marketing
he inﬂuenza vaccination, participants who were marketing expert,
dentiﬁed the use of trusted and informed sources (e.g. doctors,
chool nurses, pharmacists) to convey the importance of inﬂuenza
accinations, and the use of schools as a place for disseminat-
ng messages, as potentially effective strategies for overcoming
esitancy.
In an effort to identify effective practices in promotional com-
unications for seasonal inﬂuenza vaccines, MacDonald et al., in
013, examined 22 studies from seven European countries. The
tudies were primarily outcome evaluations of communication
fforts, including those promoting vaccination to the general pub-
ic, to speciﬁc populations (e.g. people aged 65 years and older) and
ealth-care workers [13]. While none of the studies they reviewed
irectly assessed the impact of promotional communications on
ublic acceptance of inﬂuenza vaccination, they did ﬁnd a num-
er of insights with respect to reducing hesitancy or resistance to
he inﬂuenza vaccination, including: (1) while the evidence base
or effective practice is fragmented and incomplete, the available
vidence does indicate that using a range of promotional commu-
ications could improve vaccine uptake (e.g. mass communication
ampaigns, personalized communications and health education);
2) social networks might be a useful channel (i.e. “Place”) to
mprove socially shared acceptance of vaccination; (3) while many
nterventions aim to affect psychosocial barriers to vaccination (e.g.
ttitudes, beliefs), very few clearly or explicitly use theories or mod-
ls of behavior change to inform and develop the intervention; and
4) personalized communications combined with improved service3 (2015) 4204–4211
delivery (i.e. “place”) appears to foster increased vaccination in
some groups (e.g. elderly adults).
9. Insights gained from commercial and
non-immunization communication efforts
In addition to immunization programs, marketing and social
marketing frameworks and principles have been used to guide
public health campaigns and efforts on a variety of health issues,
including tobacco cessation and prevention, reproductive health,
physical activity, HIV/AIDS prevention, nutrition, and family plan-
ning [19,24,36,37]. A number of studies have described how the
frameworks were applied and/or lessons learned in the applica-
tion [e.g. 24,37–40]. In addition, a number of studies have used
systematic reviews to more broadly identify and describe lessons
learned, effective practices and insights gained from the application
of marketing, social marketing, and private-sector or commercial
communication approaches [e.g. 24,36,41–45]. Key ﬁndings from
these efforts when it comes to addressing or reducing vaccine hes-
itancy include:
• Marketing and social marketing approaches and principles can be
effective but effectiveness varies and is not guaranteed.  In a review
of the effectiveness of social marketing interventions for health
improvement, Gordon et al. found evidence that social market-
ing interventions could work with a range of groups, in different
settings, and could work upstream as well as with the indi-
viduals [24,45]. A number of the interventions they assessed
produced a range of positive effects, from policy adoption to
behavior change to increased awareness and/or attitude change.
They also found, however, circumstances in which social mar-
keting interventions had no effect on the cognitive or behavioral
outcomes of interest, as well as a number of instances where
evaluation was  weak or missing. The studies included in the
review found stronger evidence of effectiveness for nutrition and
alcohol, tobacco, and illicit drug use, and mixed results for phys-
ical activity-related efforts. Conversely, a systematic review of
alcohol prevention interventions based on social marketing prin-
ciples was unable to conclude whether there was an effect on
alcohol-related attitudes and behaviors [40]. There was evidence
that some of interventions were able to achieve awareness and
knowledge increases, but little evidence of effects beyond that.
While Helmig and Thaler’s later review of the effectiveness of
social marketing found that around half of the analyzed articles
measured behavior change, they also found many that focused on
cognitive mediators or outcomes, with uncertain link to behavior
[42].
• Context matters, as multiple factors typically determine the suc-
cess of efforts designed to inﬂuence or shape consumer behavior.
Aschemann-Witzel et al. undertook a case-study analysis of 27
recent and successful commercial food and beverage market-
ing cases in an effort to identify lessons for strengthening public
health campaigns [46]. Their analysis focused on identifying the
major factors behind the success of commercial food market-
ing campaigns involving nutrition and health products, with “six
clusters of success factors” emerging. Each cluster subsumed
two  or three elements, with the six general factors being “Data
and Knowledge” (e.g. good research and strong insights into
consumer behavior); “Emotions” (e.g. focus on the emotional
side of messages, allowing for more emotional engagement by
consumers); “Endorsement” (i.e. the use of different forms of
endorsement to create trust and credibility); “Community” (e.g.
focus on what appeals to general human or social values, evok-
ing a sense of shared values); “Media” (i.e. choosing the best
media match or the right combination of media, with television
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often being important); and “Why and How” (i.e. the facilitation
of the consumer’s ability to understand and act upon the main
message).
Message tactics often have a signiﬁcant inﬂuence on intentions
toward health-related recommendations.  Keller and Lehmann’s
meta-analysis of 60 studies involving 22,500 participants, exam-
ined the inﬂuence of 22 messaging tactics and six individual
(i.e. message receiver) characteristics on intentions to comply
with health recommendations [44]. Their key ﬁndings included
the following: (1) low-involvement audiences are more per-
suaded by moderately fearful gain-framed messages, references
to other people (e.g. friends, family members), vivid messages,
and strong source credibility; (2) high-involvement audiences
prefer data and strong messages that are also moderately fearful;
(3) younger audiences are more inﬂuenced by references to social
consequences, whereas older audiences are more inﬂuenced by
physical consequences; and (4) women respond to emotional
messages with social consequences for oneself or health con-
sequences to their near and dear ones, while men  are more
inﬂuenced by unemotional messages that emphasize personal
physical health consequences. Overall, emphasizing social and
physical consequences in an emotional format was an approach
they concluded was most likely to have the broadest inﬂuence or
impact.
Campaigns, messages and materials should be guided by, and tail-
ored to, targeted populations or individuals.  As the three points
above strongly suggest, much evidence and experience suggests
that health-related communications are often more effective
when tailored according to the knowledge, beliefs, attitudes and
current behaviors of targeted populations and audiences. Mack-
ert suggested that one of the disciplines used by advertising
agencies throughout the world – account planning – may  be help-
ful when doing this [47]. According to Mackert, account planning
brings at least three speciﬁc elements into the campaign and mes-
saging process: (1) it seeks to explicitly link relevant consumer
or target population information and insights into the primary
communication messages and materials; (2) it places emphasis
on bringing the “voice of the consumer” into the messaging and
communication materials; and (3) it provides a “template” or
generalized format for going from a general strategy to speciﬁc
tactics. This “template” is called a creative brief – and generally
requires answers to questions like: why are we  advertising or
communicating at all? What is the communication or messag-
ing trying to achieve? Who  are we talking to? What do we know
about our target audience? What is the main point or idea we
need to communicate? What is the best way  of conveying that
idea? How do we know we are right?
Marketing, social marketing and commercial sector communication
practices and principles can increase the likelihood of positive cogni-
tive and behavioral outcomes but also bring the need for resources.
In addition to requiring resources and time to undertake research
that can be used as the foundation for communications, mes-
sages, and materials [24], marketing and social marketing efforts
often are – and need to be – multifaceted (e.g. use a num-
ber of media and communication channels to reach members
of targeted populations) [18,37,45]. In looking at trends in the
practice of health communication campaigns, Noar and Heard
noted that the most effective campaigns are those where behav-
ioral determinants are well understood, where social media and
interpersonal communication are part of the strategy, and where
members of targeted subpopulations are highly exposed to the
messages and materials, including because of factors such as vis-
ibility, repetition, and long-term exposure [41]. They also noted
that while many campaigns have failed to invest in evaluation,
there is a growing recognition of the importance of rigorous
outcome evaluation, including the use of controlled efﬁcacy3 (2015) 4204–4211 4209
trials to test campaign materials before implementing them on a
larger scale in community-level campaigns. Immunization pro-
grams and advocates who  apply marketing and social marketing
practices and principles in an effort to reduce or address vaccine
hesitancy, need to recognize that their efforts must be large or sig-
niﬁcant enough to achieve a measureable impact and that they
must have the means in place to measure the impact.
10. Social marketing of immunization to children
Historically, children have not been systematically educated in
schools about vaccines, which can later result in parents and adults
not having an understanding or appreciation of the risks of vaccine
preventable diseases and the beneﬁts of immunization to the health
and well-being of communities as well as individuals. While public
health campaigns, media stories, and information from health-care
professionals, provide many opportunities for people to learn about
vaccines beyond schools, these routes can miss many in the overall
population. By contrast, older generations understand the value of
vaccines because as children they personally experienced or saw
ﬁrst-hand the impact and harm cause by vaccine preventable dis-
eases. Now that most vaccine preventable diseases have become
much less prevalent and visible as a result of high vaccine uptake,
vaccine education efforts have become important surrogates and
substitutes for personal experience. Ensuring education and knowl-
edge dissemination about vaccines among children, adolescents
and young adults – including through school-based programs –
may  be a good opportunity to foster parental acceptance as well as
shape the future vaccine acceptance behavior of parents and other
adults. For instance, Bartolini et al. reported that a demonstration
project in 2008 involving 12 primary schools in Peru, helped fos-
ter parent acceptance of HPV vaccination for girls aged 11 and 12
[48]. The high levels of social media use among children means it
is also possible to reach and inﬂuence children outside of schools.
Peer-group provision or sharing of information is both common
and inﬂuential, and ﬁnding ways to use those channels to educate
young people about vaccine preventable diseases and the impor-
tance of vaccines, may  provide additional opportunities to shape
future vaccine beliefs and behaviors.
11. Conclusions: using marketing and social marketing to
address vaccine hesitancy
This review provides support for the SAGE Working Group’s con-
clusion that marketing and communication practices along with
social marketing frameworks and principles likely have much util-
ity when it comes to addressing vaccine hesitancy. As this review
illustrates, marketing and social marketing practices and princi-
ples have been used by a number of programs in a number of
settings and contexts to foster vaccine acceptance. They have done
so by increasing awareness of immunization recommendations,
addressing the questions and concerns of those who  were hesitant,
and framing (i.e. talking about) vaccines and vaccination recom-
mendations in ways that increase understanding and motivate
behavior. Related to this, marketing and social marketing frame-
works highlight the important and central role of “value” in the
context of behavior or behavior change. People are motivated to
act – whether it is purchasing a product or service, or adopting an
advocated behavior, when doing so provides them with, or helps
them achieve, something that they value. As commercial marketers
well know, people care most about beneﬁts, and they care most
when the information about the key beneﬁts are communicated
in a meaningful way (e.g. through stories, with emotion, and with
a compelling message). It is important that immunization advo-
cates and programs recognize the power of value demonstrating
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nd the need for powerful messages in their efforts to foster vaccine
cceptance. Social marketing and commercial sector marketing
nd communication practices provide approaches and methods for
ringing forth the value that facilitates or impedes acceptance of
accines or vaccination recommendations.
Commercial and social marketing approaches and principles
lso help draw attention to two other important considerations
ith regard to vaccine hesitancy and acceptance. The ﬁrst is that
romotion represents or provides just one category of factors.
here are at least three other categories of factors that need to be
aken into consideration in addressing vaccine hesitancy and accep-
ance, i.e. product, price and place. Immunization advocates and
rograms need to examine whether elements in these categories
re impeding vaccine acceptance or fostering vaccine hesitancy.
nconvenient access, limited availability of vaccination services,
nd inadequately trained vaccination providers all have the poten-
ial to create or increase hesitancy. Similar to successful commercial
arketers, immunization programs need to go beyond promotions
nd communications in their efforts to achieve the greatest suc-
ess possible. Programs should be mindful that “one-size-ﬁts-all”
pproaches to communications and messaging often do not lead to
he greatest success. Rather, it is more likely that several different
arent or population segments exist, each with a different set of val-
es, interests and needs. As Keller and Lehman’s study illustrates,
he effectiveness of message tactics often varies across segments
44]. Thus, maximizing success on the promotion and communica-
ion front will likely require a portfolio of messages and materials,
ncluding those speciﬁcally tailored for vaccine-hesitant parents or
ndividuals.
Immunization advocates and programs need to recognize that
eveloping effective marketing and communication strategies is
ot simple, nor is the application of marketing and social marketing
ractices and principles a “magic bullet.” The following consider-
tions need to be taken into account:
1) Designing effective strategies, particularly those directed at
hesitant and reluctant subpopulations, requires time and
resources. Efforts must be made to learn how members of
targeted populations perceive vaccines and vaccination rec-
ommendations, and what factors could potentially facilitate
acceptance. As the examples described here illustrate, it is also
likely the case that efforts will need to encompass developing,
disseminating, and providing training to health-care workers.
2) In using marketing and social marketing practices and princi-
ples, immunization programs and advocates need to be aware
that the word “marketing” can be problematic as a label. Despite
the efforts and desire of both commercial and social marketers,
many non-marketers associate the term with “selling” or with
efforts that seek to persuade individuals to buy things they do
not need or do something that they otherwise would not do.
It is also the case that efforts made by immunization programs
and vaccine manufacturers to “market” or promote vaccines has
sometimes been met  with criticism [49,50].
3) It is probable that some groups or individuals, such as those
adamantly opposed to vaccines and vaccinations, are unlikely
to be persuaded or to change their beliefs even if marketing and
social marketing practices are used as a foundation. It is more
likely these practices and principles have value with those who
are willing to consider vaccinations.
4) It is likely that one of the potential sources or causes of hesi-
tancy – the “product” (i.e. a speciﬁc vaccine or the immunization
schedule) – represents a relatively inﬂexible category when it
comes to developing a marketing strategy. While there are and
will continue to be ongoing efforts to improve the safety and
efﬁcacy of recommended vaccines and immunization sched-
ules, the timeframes for vaccinations often do not lend to3 (2015) 4204–4211
adjustment based on consumer preferences. Science and pub-
lic health priorities will always be high on the list for many
aspects of immunization recommendations and programs, even
if or when those priorities do not align perfectly with parent
preferences.
For reasons such as these, social and commercial marketing
practices and principles provide value, but are also not without lim-
itations. There thus will be situations and circumstances in which
other approaches – including health-care worker involvement and
training, vaccine education efforts in schools and other settings,
and upstream policies that facilitate vaccination – will continue to
be needed.
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